JD three-lens brief
Evidence-based stock research on JD. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $39.91 — 32% above current (36 analysts). · Negative free cash flow last quarterly (-$10.44B).
- Analyst mean target $39.91 — 32% above current (36 analysts).
- Negative free cash flow last quarterly (-$10.44B).
- Debt-to-equity of 36.5 — balance-sheet-heavy.
JD closed at $30.27 (+0.97%) as of 2026-04-25. Market cap: $41.34B. P/E (trailing) 16.0. Positives: analyst mean target $39.91 — 32% above current (36 analysts).. Concerns: negative free cash flow last quarterly (-$10.44B).; debt-to-equity of 36.5 — balance-sheet-heavy.. Last quarter: Revenue $352.28B, net income -$2.71B, free cash flow -$10.44B.
Why three lenses on JD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine JDacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/JD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath JD brief"></iframe>